Mackerel

Why It Matters for Longevity

Atlantic mackerel provides among the highest concentrations of EPA and DHA of any commonly available fish — approximately 2.5 g per 100 g cooked — alongside exceptional vitamin B12, vitamin D, and selenium. Omega-3 fatty acids EPA and DHA reduce systemic inflammation, lower triglycerides, improve endothelial function, and are among the most evidence-supported nutrients for cardiovascular longevity.

Fish-oil supplementation significantly alters myocardial phospholipid fatty acid composition, increasing EPA and DHA directly in cardiac tissue — demonstrating that marine omega-3s from mackerel and similar fatty fish reach and modify heart tissue (Metcalf et al., 2007, Am J Clin Nutr).

A meta-analysis of prospective studies found that fish consumption is inversely associated with risk of heart failure; each additional serving per week of fatty fish was associated with a statistically significant reduction in heart failure risk, with omega-3 fatty acids identified as the primary mechanism (Djoussé et al., 2012, Clin Nutr).

Among 191,558 participants across 58 countries, fish consumption of 175–350 g/week was associated with significantly lower risk of cardiovascular mortality and myocardial infarction, supporting Atlantic mackerel as a cornerstone longevity food (Mohan et al., 2021, JAMA Intern Med).

The Omega-3 Index

One of the clearest mechanistic links between mackerel consumption and cardiac protection is the omega-3 index — the proportion of EPA + DHA in red blood cell membranes, expressed as a percentage of total fatty acids. This biomarker reflects long-term dietary intake far better than a single plasma measurement, and it tracks directly with how much EPA and DHA have been incorporated into tissue.

Harris and von Schacky proposed the omega-3 index as a graded, independent risk factor for coronary heart disease death: an index below 4% was associated with the highest risk, while an index at or above 8% was associated with the greatest cardioprotection (Harris & von Schacky, 2004, Prev Med). A subsequent analysis of 10 prospective cohort studies confirmed this dose-response: each one standard deviation increase in the omega-3 index (roughly 2 percentage points) was associated with a hazard ratio of 0.85 for fatal coronary heart disease, translating to approximately 30% lower CHD mortality risk comparing an index of 4% to 8% (Harris et al., 2017, Atherosclerosis).

Atlantic mackerel is one of the most efficient foods for raising the omega-3 index. A single 100 g serving delivers roughly 2.5 g of EPA + DHA — the amount shown in supplementation trials to shift erythrocyte membrane composition meaningfully within 4–8 weeks. Most Western adults have an omega-3 index between 4–6%; two servings of Atlantic mackerel per week is sufficient to push most people toward the target range above 8%.

Cardiovascular Effects Beyond Omega-3s

A controlled dietary trial in 15 healthy volunteers found that two weeks on a mackerel and herring diet produced significant reductions in serum triglycerides, total cholesterol, and LCAT activity, alongside markedly lower systolic and diastolic blood pressure and reduced plasma noradrenaline — changes that returned to baseline after three months off the diet (Singer et al., 1983, Atherosclerosis). The blood pressure effect is noteworthy: reduced noradrenaline output suggests a sympathetic nervous system dampening mechanism, separate from the lipid pathway.

A large meta-analysis of 38 randomized controlled trials encompassing 149,051 participants found that omega-3 supplementation was associated with a 13% reduction in non-fatal myocardial infarction (RR 0.87, 95% CI 0.81–0.93), a 9% reduction in coronary heart disease events (RR 0.91), and a 7% reduction in cardiovascular mortality (RR 0.93) (Khan et al., 2021, EClinicalMedicine). Importantly, dose matters: a companion meta-regression found that the protective effect of EPA/DHA on fatal MI was especially strong, with an RR of 0.65 for fatal myocardial infarction (Bernasconi et al., 2021, Mayo Clin Proc).

The Resolvin and Protectin Pathway

The anti-inflammatory effect of EPA and DHA is not simply a matter of displacing pro-inflammatory arachidonic acid from membrane phospholipids, though that substitution is part of the mechanism. Both EPA and DHA are enzymatically converted into a family of specialized pro-resolving mediators (SPMs) — resolvins, protectins, and maresins — that actively terminate inflammatory cascades rather than merely suppressing them.

EPA gives rise to E-series resolvins, while DHA is the precursor for D-series resolvins and protectin D1 (also called neuroprotectin D1 in neural tissue). These compounds act at picomolar to nanomolar concentrations — orders of magnitude more potent than their fatty acid precursors — to shorten neutrophil recruitment, promote macrophage-mediated clearance of apoptotic debris, and restore vascular endothelial homeostasis. The shared biosynthetic pathway runs through 17-hydroperoxy-DHA and 18-hydroperoxy-EPA as key intermediates (Weylandt et al., 2012, Prostaglandins Other Lipid Mediators). This downstream signaling explains why dietary EPA and DHA from sources like Atlantic mackerel produce broader and more durable anti-inflammatory effects than expected from their direct incorporation into membranes alone.

Omega-3s and Muscle Preservation in Aging

Sarcopenia — the age-related loss of skeletal muscle mass and function — is among the most consequential physiological changes driving frailty, fall risk, and loss of independence in older adults. EPA and DHA slow this process through at least two mechanisms: incorporation into sarcolemmal phospholipids that increases membrane fluidity and insulin receptor sensitivity, and activation of mTORC1-dependent muscle protein synthesis signaling downstream of anabolic stimuli.

A meta-analysis of 10 randomized controlled trials found that omega-3 supplementation in elderly participants produced modest but statistically significant increases in muscle mass (0.33 kg, 95% CI: 0.05–0.62 kg) and improvements in functional performance (timed up-and-go test improvement of 0.30 seconds). At doses above 2 g/day of EPA + DHA — approximately the amount delivered by a 100 g serving of Atlantic mackerel — muscle mass gains increased to 0.67 kg (95% CI: 0.16–1.18 kg), with extended supplementation over 6 months associated with meaningful improvements in walking speed (Huang et al., 2020, Nutrients). The practical implication is that regular Atlantic mackerel consumption maintains the EPA + DHA plasma concentrations required to support this anabolic effect on aging skeletal muscle without supplementation.

Vitamin D and B12 Content

Mackerel is one of the few foods that delivers meaningful vitamin D through diet alone. The fat-soluble nature of vitamin D3 means that the high fat content of mackerel improves absorption within the same meal. Vitamin D regulates blood pressure via endothelial and smooth muscle cell receptors, and deficiency has been associated with higher cardiovascular mortality in observational data.

Vitamin B12 content is exceptional: 19 mcg per 100 g cooked, far exceeding the 2.4 mcg DV in a single serving. B12 functions as a cofactor in the remethylation of homocysteine to methionine; inadequate B12 raises plasma homocysteine, an established independent cardiovascular risk factor. Regular mackerel consumption maintains the B12 status needed to keep homocysteine in check without supplementation.

Coenzyme Q10

Atlantic mackerel is one of the richer dietary sources of coenzyme Q10 (ubiquinone, CoQ10), providing approximately 4–6 mg per 100 g cooked — comparable to beef heart and substantially more than chicken breast or most plant foods. CoQ10 functions as an electron carrier in the mitochondrial respiratory chain (complexes I through III) and as a fat-soluble antioxidant in cell membranes. Its concentration in cardiac muscle is particularly high because heart cells sustain continuous aerobic demand; CoQ10 depletion in myocardial tissue is associated with progressive heart failure, and statin use — which inhibits the same mevalonate pathway that synthesizes CoQ10 — accelerates this depletion.

A GRADE-assessed meta-analysis of 26 randomized controlled trials in 1,831 patients with cardiometabolic disorders found that CoQ10 supplementation significantly reduced systolic blood pressure by 4.77 mmHg (95% CI: −6.57 to −2.97 mmHg). The effect followed a U-shaped dose-response, with the greatest reductions at approximately 100–200 mg/day; effects were more pronounced in patients with diabetes and dyslipidemia and in trials exceeding 12 weeks (Zhao et al., 2022, Adv Nutr). Dietary CoQ10 from mackerel contributes a smaller dose than supplementation trials use, but as a fat-soluble compound it benefits from the high fat content of mackerel, which enhances intestinal absorption via the same chylomicron pathway as vitamins D and K.

Mercury Profile

Atlantic mackerel (Scomber scombrus) is consistently low in mercury — typically below 0.05 ppm — because it is a fast-growing, short-lived, mid-chain pelagic fish. King mackerel (Scomberomorus cavalla) and Spanish mackerel are different species with much higher mercury loads (>0.7 ppm) and should be avoided. The FDA/EPA advisory for vulnerable populations explicitly lists Atlantic mackerel as a "best choice" fish for twice-weekly consumption, while king mackerel appears on the "avoid" list.

How to Use It

Use Atlantic or Pacific mackerel — avoid king mackerel and Spanish mackerel, which have high mercury levels. Pairs with lemon, capers, and mustard. Grill, broil, or use canned. The high omega-3 content benefits from minimal cooking to avoid oxidation.

What to Pair It With

Flavor Profile

Rich, oily, savory, strong. Aroma is distinctly fishy and briny. Texture is firm, flaky, and oily. Among the more assertively flavored fish — benefits from acid (lemon, vinegar) to balance richness.

The Science

• Metcalf et al., 2007, Am J Clin Nutr: Fish-oil supplementation alters myocardial phospholipid fatty acid composition, demonstrating direct cardiac tissue incorporation of EPA and DHA from dietary fatty fish.
• Djoussé et al., 2012, Clin Nutr: Meta-analysis of prospective studies — fish consumption inversely associated with heart failure risk; each additional weekly serving of fatty fish significantly reduced heart failure incidence.
• Mohan et al., 2021, JAMA Intern Med: Among 191,558 participants in 58 countries, fish consumption of 175–350 g/week associated with lower cardiovascular mortality and myocardial infarction.
• Harris & von Schacky, 2004, Prev Med: Introduced the omega-3 index as a graded cardiac mortality risk factor; index ≥8% confers greatest protection, ≤4% the least.
• Harris et al., 2017, Atherosclerosis: Meta-analysis of 10 cohort studies — each 2-percentage-point rise in omega-3 index associated with ~30% lower fatal CHD risk (HR 0.85 per SD).
• Khan et al., 2021, EClinicalMedicine: 38 RCTs, 149,051 participants — omega-3 supplementation reduced non-fatal MI by 13%, CHD events by 9%, cardiovascular mortality by 7%.
• Bernasconi et al., 2021, Mayo Clin Proc: 40 RCTs, 135,267 participants — EPA/DHA reduced fatal MI risk by 35% (RR 0.65); protective effect dose-dependent.
• Singer et al., 1983, Atherosclerosis: Two-week mackerel diet in 15 healthy volunteers lowered serum triglycerides, total cholesterol, systolic and diastolic blood pressure, and plasma noradrenaline.
• Weylandt et al., 2012, Prostaglandins Other Lipid Mediators: EPA and DHA enzymatically converted to E- and D-series resolvins and protectin D1 via 18-hydroperoxy-EPA and 17-hydroperoxy-DHA intermediates; these specialized pro-resolving mediators actively terminate inflammatory cascades at picomolar concentrations.
• Huang et al., 2020, Nutrients: Meta-analysis of 10 RCTs in elderly — omega-3 supplementation increased muscle mass by 0.33 kg overall, rising to 0.67 kg at doses >2 g/day; walking speed improved with extended supplementation (>6 months), supporting anti-sarcopenic effect.
• Zhao et al., 2022, Adv Nutr: GRADE meta-analysis, 26 RCTs, 1,831 patients — CoQ10 supplementation reduced systolic blood pressure by 4.77 mmHg (95% CI −6.57 to −2.97); U-shaped dose-response with peak effect at 100–200 mg/day.

References

1. Metcalf RG, James MJ, Gibson RA, et al. Effects of fish-oil supplementation on myocardial fatty acids in humans. Am J Clin Nutr. 2007;85(5):1222-1228. PMID: 17490956. doi:10.1093/ajcn/85.5.1222
2. Djoussé L, Akinkuolie AO, Wu JH, et al. Fish consumption, omega-3 fatty acids and risk of heart failure: a meta-analysis. Clin Nutr. 2012;31(6):846-853. PMID: 22682084. doi:10.1016/j.clnu.2012.03.012
3. Mohan D, Mente A, Dehghan M, et al. Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries. JAMA Intern Med. 2021;181(5):631-649. PMID: 33683310. doi:10.1001/jamainternmed.2021.0036
4. Harris WS, von Schacky C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med. 2004;39(1):212-220. PMID: 15208005. doi:10.1016/j.ypmed.2004.02.030
5. Harris WS, Del Gobbo L, Tintle NL. The Omega-3 Index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies. Atherosclerosis. 2017;262:51-54. PMID: 28511049. doi:10.1016/j.atherosclerosis.2017.05.007
6. Khan SU, Lone AN, Khan MS, et al. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis. EClinicalMedicine. 2021;38:100997. PMID: 34505026. doi:10.1016/j.eclinm.2021.100997
7. Bernasconi AA, Wiest MM, Lavie CJ, et al. Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials. Mayo Clin Proc. 2021;96(2):304-313. PMID: 32951855. doi:10.1016/j.mayocp.2020.08.034
8. Singer P, Jaeger W, Wirth M, et al. Lipid and blood pressure-lowering effect of mackerel diet in man. Atherosclerosis. 1983;49(1):99-108. PMID: 6316995. doi:10.1016/0021-9150(83)90011-4
9. Weylandt KH, Chiu CY, Gomolka B, et al. Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. Prostaglandins Other Lipid Mediators. 2012;97(3-4):73-82. PMID: 22326554. doi:10.1016/j.prostaglandins.2012.01.005
10. Huang YH, Chiu WC, Hsu YP, Lo YL, Wang YH. Effects of Omega-3 Fatty Acids on Muscle Mass, Muscle Strength and Muscle Performance among the Elderly: A Meta-Analysis. Nutrients. 2020;12(12):3739. PMID: 33291698. doi:10.3390/nu12123739
11. Zhao D, Liang Y, Dai S, et al. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A GRADE-Assessed Systematic Review and Meta-Analysis. Adv Nutr. 2022;13(6):2180-2194. PMID: 36130103. doi:10.1093/advances/nmac100

Key Nutrients